Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
House conservatives to lead prayer for end to...
GOP senators push for Charlie Kirk statue in...
Biden autopen investigation ‘has heated up’ as DOJ...
States sue Trump admin over billions in looming...
NASA’s ‘quiet’ supersonic jet completes first flight in...
Trump claims Asia tour returned ‘trillions’ to US...
‘Unprecedented’ panel of federal judges will tackle antisemitism...
Schumer, Dems call ‘bull—-‘ on Trump administration over...
US rescue teams to descend on hard-hit Caribbean...
Republicans dub Fetterman ‘voice of reason’ after he...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

by admin March 13, 2025
March 13, 2025
FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

The Food and Drug Administration’s (FDA) top lawyer, who was appointed to the position just this week, has resigned, according to a Thursday morning post on X.

‘Hilary K. Perkins has resigned from her position as Chief Counsel of FDA, effectively immediately,’ the FDA’s official X account posted.  

Perkins – a former assistant director under Biden’s Department of Justice (DOJ) in the consumer protection agency – was selected on Tuesday by acting general Sean Keveney in the Department of Health and Human Services (HHS) as part of a ‘reorganization’ effort by the department, according to an HHS news release.

She previously defended abortion pill access in a high-profile case under Biden’s DOJ, and HHS officials were reportedly unhappy with the decision to appoint Perkins but were overruled by White House officials, according to a report from Axios this week.

‘We’ve been able to recruit higher quality personnel to HHS than in any time in its history,’ HHS Secretary Robert F. Kennedy, Jr., said in a statement Tuesday at the announcement of Perkins’ assignment on Tuesday. ‘These are individuals who will return the agency to gold-standard science, evidence-based medicine, and recalibrate its trajectory toward public health rather than industry profiteering.’

Fox News Digital has reached out to the HHS and FDA for comment.

This is a breaking story, check back for updates.

This post appeared first on FOX NEWS

previous post
Brian Leni: Latest Mining Stock Wins and How I’m Deploying Cash Now
next post
Senate Republicans coin ‘Schumer shutdown’ ahead of critical vote on Trump spending bill

You may also like

Trump pledges to release files on JFK, MLK...

January 20, 2025

Meet Natalie Harp, Trump’s ‘valuable resource’ who lawmakers...

December 11, 2024

‘Blatantly unconstitutional’: US judge temporarily blocks Trump’s ban...

January 24, 2025

‘Squad’ Dem Ayanna Pressley trashes Elon Musk, calling...

February 5, 2025

Does Iran’s hacking of the Trump campaign prove...

September 25, 2024

Trump says Israel and Iran ‘have to fight...

June 16, 2025

SEN. RAND PAUL: Kennedy is confronting ‘corrupt’ health...

May 28, 2025

Schumer refuses to step down as Senate Dem...

March 24, 2025

Denmark in Trump’s crosshairs as Vance makes ambitious...

March 29, 2025

Senate Majority Leader Thune says this is the...

February 14, 2025

Recent Posts

  • House conservatives to lead prayer for end to political violence, government shutdown
  • GOP senators push for Charlie Kirk statue in Trump’s National Garden of American Heroes
  • Biden autopen investigation ‘has heated up’ as DOJ looks at Delaware, DC: source
  • States sue Trump admin over billions in looming cuts to SNAP, food stamps
  • NASA’s ‘quiet’ supersonic jet completes first flight in potential breakthrough for commercial air travel

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (946)
    • Investing (3,304)
    • Politics (4,045)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.